CCEL
- Cryo-Cell International, Inc.
()
Overview
Company Summary
Cryo-Cell International, Inc. (CCEL) is a company that specializes in the field of cellular medicine, specifically in the collection, processing, and cryogenic preservation of stem cells from umbilical cord blood.
Cord blood is the blood that remains in the umbilical cord and placenta after a baby is born. This blood is a rich source of stem cells, which are the building blocks of the body's immune and blood systems. These stem cells have the potential to treat a wide range of diseases and conditions, including certain cancers, blood disorders, immune system disorders, and genetic disorders.
Cryo-Cell International operates a state-of-the-art facility where they collect and process cord blood samples. They use advanced technology and strict quality control procedures to ensure the viability and safety of the collected stem cells. These stem cells are then cryogenically preserved, which involves freezing them at ultra-low temperatures for long-term storage.
The company offers expectant parents the opportunity to store their baby's cord blood stem cells for potential future medical use. By preserving these stem cells, parents can secure a potential source of treatment for their child or potentially other family members if they face medical conditions that can be treated with stem cells.
In addition to cord blood banking, Cryo-Cell International also provides other cellular therapy services and products. They offer services such as cord tissue preservation, where stem cells are collected from the umbilical cord tissue, as well as treatment and research services related to cellular medicine.
Overall, Cryo-Cell International focuses on advancing the field of cellular medicine through the collection, processing, and preservation of stem cells, with the ultimate goal of providing healthcare solutions and treatments for a variety of diseases and conditions.